Vanguard Group
OKUR

Vanguard Group’s OnKure Therapeutics OKUR Stock Holding History

Vanguard Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.82M Sell
626,593
-51,633
-8% -$155K ﹤0.01% 3589
2025
Q3 		$1.87M Sell
678,226
-28,507
-4% -$70.6K ﹤0.01% 3602
2025
Q2 		$1.69M Hold
706,733
– – ﹤0.01% 3590
2025
Q1 		$3.04M Hold
706,733
– – ﹤0.01% 3347
2024
Q4 		$6.08M Buy
706,733
+618,523
+701% +$9.36M ﹤0.01% 3187
2024
Q3 		$1.5M Hold
88,210
– – ﹤0.01% 3645
2024
Q2 		$1.33M Sell
88,210
-8,870
-9% -$150K ﹤0.01% 3696
2024
Q1 		$1.61M Sell
97,080
-809
-0.8% -$13.3K ﹤0.01% 3661
2023
Q4 		$1.57M Buy
97,889
+374
+0.4% +$23.3K ﹤0.01% 3683
2023
Q3 		$7.43M Buy
97,515
+1,730
+2% +$118K ﹤0.01% 3066
2023
Q2 		$6.28M Buy
95,785
+63,987
+201% +$5.16M ﹤0.01% 3198
2023
Q1 		$1.9M Hold
31,798
– – ﹤0.01% 3695
2022
Q4 		$741K Sell
31,798
-83
-0.3% -$2.2K ﹤0.01% 3999
2022
Q3 		$1.07M Hold
31,881
– – ﹤0.01% 3976
2022
Q2 		$845K Sell
31,881
-4,207
-12% -$97.9K ﹤0.01% 4141
2022
Q1 		$1.06M Sell
36,088
-672
-2% -$37.6K ﹤0.01% 4185
2021
Q4 		$3.14M Sell
36,760
-1,015
-3% -$74.5K ﹤0.01% 3859
2021
Q3 		$2.81M Buy
37,775
+1,154
+3% +$97.9K ﹤0.01% 3940
2021
Q2 		$3.42M Buy
+36,621
New +$4.08M ﹤0.01% 3780

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Vanguard Group's OKUR Position: Q4 2025 in Review

Vanguard Group reduced its OnKure Therapeutics (OKUR) stake by 7.6% in Q4 2025, selling an estimated $155K and leaving 626,593 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

Vanguard Group first reported a position in OKUR in Q2 2021 and has held it in 19 quarters since. The position peaked at $7.43M in Q3 2023. 44 funds tracked by Wall St. Rank hold OKUR as of Q4 2025.

  • Vanguard Group held 626,593 shares of OnKure Therapeutics worth $1.82M as of Q4 2025.
  • Vanguard Group sold 51,633 OnKure Therapeutics shares in Q4 2025, an estimated $155K.
  • OnKure Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3589 holding.
  • Vanguard Group first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's OnKure Therapeutics position peaked at $7.43M in Q3 2023.
  • 44 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.